TABLE OF CONTENTS 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Pediatric Drugs and Vaccines 1.2 Key Market Segments 1.2.1 Pediatric Drugs and Vaccines Segment by Type 1.2.2 Pediatric Drugs and Vaccines Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Pediatric Drugs and Vaccines Market Overview 2.1 Global Market Overview 2.1.1 Global Pediatric Drugs and Vaccines Market Size (M USD) Estimates and Forecasts (2017-2028) 2.1.2 Global Pediatric Drugs and Vaccines Sales Estimates and Forecasts (2017-2028) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Pediatric Drugs and Vaccines Market Competitive Landscape 3.1 Global Pediatric Drugs and Vaccines Sales by Manufacturers (2017-2022) 3.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Manufacturers (2017-2022) 3.3 Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4 Global Pediatric Drugs and Vaccines Average Price by Manufacturers (2017-2022) 3.5 Manufacturers Pediatric Drugs and Vaccines Sales Sites, Area Served, Product Type 3.6 Pediatric Drugs and Vaccines Market Competitive Situation and Trends 3.6.1 Pediatric Drugs and Vaccines Market Concentration Rate 3.6.2 Global 5 and 10 Largest Pediatric Drugs and Vaccines Players Market Share by Revenue 3.6.3 Mergers & Acquisitions, Expansion 4 Pediatric Drugs and Vaccines Industry Chain Analysis 4.1 Pediatric Drugs and Vaccines Industry Chain Analysis 4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of Pediatric Drugs and Vaccines Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 Industry Policies 6 Pediatric Drugs and Vaccines Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2022) 6.3 Global Pediatric Drugs and Vaccines Market Size Market Share by Type (2017-2022) 6.4 Global Pediatric Drugs and Vaccines Price by Type (2017-2022) 7 Pediatric Drugs and Vaccines Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Pediatric Drugs and Vaccines Market Sales by Application (2017-2022) 7.3 Global Pediatric Drugs and Vaccines Market Size (M USD) by Application (2017-2022) 7.4 Global Pediatric Drugs and Vaccines Sales Growth Rate by Application (2017-2022) 8 Pediatric Drugs and Vaccines Market Segmentation by Region 8.1 Global Pediatric Drugs and Vaccines Sales by Region 8.1.1 Global Pediatric Drugs and Vaccines Sales by Region 8.1.2 Global Pediatric Drugs and Vaccines Sales Market Share by Region 8.2 North America 8.2.1 North America Pediatric Drugs and Vaccines Sales by Country 8.2.2 U.S. 8.2.3 Canada 8.2.4 Mexico 8.3 Europe 8.3.1 Europe Pediatric Drugs and Vaccines Sales by Country 8.3.2 Germany 8.3.3 France 8.3.4 U.K. 8.3.5 Italy 8.3.6 Russia 8.4 Asia Pacific 8.4.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Region 8.4.2 China 8.4.3 Japan 8.4.4 South Korea 8.4.5 India 8.4.6 Southeast Asia 8.5 South America 8.5.1 South America Pediatric Drugs and Vaccines Sales by Country 8.5.2 Brazil 8.5.3 Argentina 8.5.4 Columbia 8.6 Middle East and Africa 8.6.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Region 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Egypt 8.6.5 Nigeria 8.6.6 South Africa 9 Key Companies Profiled 9.1 Merck and Co., Inc. (USA) 9.1.1 Merck and Co., Inc. (USA) Pediatric Drugs and Vaccines Basic Information 9.1.2 Merck and Co., Inc. (USA) Pediatric Drugs and Vaccines Product Overview 9.1.3 Merck and Co., Inc. (USA) Pediatric Drugs and Vaccines Product Market Performance 9.1.4 Merck and Co., Inc. (USA) Business Overview 9.1.5 Merck and Co., Inc. (USA) Pediatric Drugs and Vaccines SWOT Analysis 9.1.6 Merck and Co., Inc. (USA) Recent Developments 9.2 Abbott Laboratories (USA) 9.2.1 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Basic Information 9.2.2 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Overview 9.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Market Performance 9.2.4 Abbott Laboratories (USA) Business Overview 9.2.5 Abbott Laboratories (USA) Pediatric Drugs and Vaccines SWOT Analysis 9.2.6 Abbott Laboratories (USA) Recent Developments 9.3 Amgen, Inc. (USA) 9.3.1 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Basic Information 9.3.2 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Overview 9.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Market Performance 9.3.4 Amgen, Inc. (USA) Business Overview 9.3.5 Amgen, Inc. (USA) Pediatric Drugs and Vaccines SWOT Analysis 9.3.6 Amgen, Inc. (USA) Recent Developments 9.4 Eli Lilly and Company (USA) 9.4.1 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Basic Information 9.4.2 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Overview 9.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Market Performance 9.4.4 Eli Lilly and Company (USA) Business Overview 9.4.5 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines SWOT Analysis 9.4.6 Eli Lilly and Company (USA) Recent Developments 9.5 F. Hoffmann-La Roche Ltd (Switzerland) 9.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Basic Information 9.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Overview 9.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Market Performance 9.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview 9.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines SWOT Analysis 9.5.6 F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments 9.6 Genentech, Inc. (USA) 9.6.1 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Basic Information 9.6.2 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Overview 9.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Market Performance 9.6.4 Genentech, Inc. (USA) Business Overview 9.6.5 Genentech, Inc. (USA) Recent Developments 9.7 GlaxoSmithKline plc. (UK) 9.7.1 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Basic Information 9.7.2 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Overview 9.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Market Performance 9.7.4 GlaxoSmithKline plc. (UK) Business Overview 9.7.5 GlaxoSmithKline plc. (UK) Recent Developments 9.8 Janssen Biologics B.V. (USA) 9.8.1 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Basic Information 9.8.2 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Overview 9.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Market Performance 9.8.4 Janssen Biologics B.V. (USA) Business Overview 9.8.5 Janssen Biologics B.V. (USA) Recent Developments 9.9 Actelion Pharmaceuticals 9.9.1 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Basic Information 9.9.2 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Overview 9.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Market Performance 9.9.4 Actelion Pharmaceuticals Business Overview 9.9.5 Actelion Pharmaceuticals Recent Developments 9.10 AstraZeneca Plc. (UK) 9.10.1 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Basic Information 9.10.2 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Overview 9.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Market Performance 9.10.4 AstraZeneca Plc. (UK) Business Overview 9.10.5 AstraZeneca Plc. (UK) Recent Developments 9.11 Boehringer Ingelheim GmbH (Germany) 9.11.1 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Basic Information 9.11.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Overview 9.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Market Performance 9.11.4 Boehringer Ingelheim GmbH (Germany) Business Overview 9.11.5 Boehringer Ingelheim GmbH (Germany) Recent Developments 9.12 Bristol-Myers Squibb Company (USA) 9.12.1 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Basic Information 9.12.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Overview 9.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Market Performance 9.12.4 Bristol-Myers Squibb Company (USA) Business Overview 9.12.5 Bristol-Myers Squibb Company (USA) Recent Developments 9.13 Allergan, Inc. (USA) 9.13.1 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Basic Information 9.13.2 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Overview 9.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Market Performance 9.13.4 Allergan, Inc. (USA) Business Overview 9.13.5 Allergan, Inc. (USA) Recent Developments 9.14 Novartis AG (Switzerland) 9.14.1 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Basic Information 9.14.2 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Overview 9.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Market Performance 9.14.4 Novartis AG (Switzerland) Business Overview 9.14.5 Novartis AG (Switzerland) Recent Developments 9.15 Novo Nordisk A/S (Denmark) 9.15.1 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Basic Information 9.15.2 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Overview 9.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Market Performance 9.15.4 Novo Nordisk A/S (Denmark) Business Overview 9.15.5 Novo Nordisk A/S (Denmark) Recent Developments 9.16 Pfizer, Inc. (USA) 9.16.1 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Basic Information 9.16.2 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Overview 9.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Market Performance 9.16.4 Pfizer, Inc. (USA) Business Overview 9.16.5 Pfizer, Inc. (USA) Recent Developments 9.17 Sanofi S.A (France) 9.17.1 Sanofi S.A (France) Pediatric Drugs and Vaccines Basic Information 9.17.2 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Overview 9.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Market Performance 9.17.4 Sanofi S.A (France) Business Overview 9.17.5 Sanofi S.A (France) Recent Developments 9.18 Shionogi Inc. (USA) 9.18.1 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Basic Information 9.18.2 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Overview 9.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Market Performance 9.18.4 Shionogi Inc. (USA) Business Overview 9.18.5 Shionogi Inc. (USA) Recent Developments 9.19 Takeda 9.19.1 Takeda Pediatric Drugs and Vaccines Basic Information 9.19.2 Takeda Pediatric Drugs and Vaccines Product Overview 9.19.3 Takeda Pediatric Drugs and Vaccines Product Market Performance 9.19.4 Takeda Business Overview 9.19.5 Takeda Recent Developments 10 Pediatric Drugs and Vaccines Market Forecast by Region 10.1 Global Pediatric Drugs and Vaccines Market Size Forecast 10.2 Global Pediatric Drugs and Vaccines Market Forecast by Region 10.2.1 North America Market Size Forecast by Country 10.2.2 Europe Pediatric Drugs and Vaccines Market Size Forecast by Country 10.2.3 Asia Pacific Pediatric Drugs and Vaccines Market Size Forecast by Region 10.2.4 South America Pediatric Drugs and Vaccines Market Size Forecast by Country 10.2.5 Middle East and Africa Forecasted Consumption of Pediatric Drugs and Vaccines by Country 11 Forecast Market by Type and by Application (2022-2028) 11.1 Global Pediatric Drugs and Vaccines Market Forecast by Type (2022-2028) 11.1.1 Global Forecasted Sales of Pediatric Drugs and Vaccines by Type (2022-2028) 11.1.2 Global Pediatric Drugs and Vaccines Market Size Forecast by Type (2022-2028) 11.1.3 Global Forecasted Price of Pediatric Drugs and Vaccines by Type (2022-2028) 11.2 Global Pediatric Drugs and Vaccines Market Forecast by Application (2022-2028) 11.2.1 Global Pediatric Drugs and Vaccines Sales (K Units) Forecast by Application 11.2.2 Global Pediatric Drugs and Vaccines Market Size (M USD) Forecast by Application (2022-2028) 12 Conclusion and Key Findings

LIST OF TABLES Table 1. Introduction of the Type Table 2. Introduction of the Application Table 3. Market Size (M USD) Segment Executive Summary Table 4. Pediatric Drugs and Vaccines Market Size (M USD) Comparison by Region (M USD) Table 5. Global Pediatric Drugs and Vaccines Sales (K Units) by Manufacturers (2017-2022) Table 6. Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2017-2022) Table 7. Global Pediatric Drugs and Vaccines Revenue (M USD) by Manufacturers (2017-2022) Table 8. Global Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2017-2022) Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Drugs and Vaccines as of 2021) Table 10. Global Market Pediatric Drugs and Vaccines Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 11. Manufacturers Pediatric Drugs and Vaccines Sales Sites and Area Served Table 12. Manufacturers Pediatric Drugs and Vaccines Product Type Table 13. Global Pediatric Drugs and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Mergers & Acquisitions, Expansion Plans Table 15. Industry Chain Map of Pediatric Drugs and Vaccines Table 16. Raw Materials Table 17. Midstream Market Analysis Table 18. Downstream Customer Analysis Table 19. Key Development Trends Table 20. Driving Factors Table 21. Pediatric Drugs and Vaccines Market Challenges Table 22. Market Restraints Table 23. Global Pediatric Drugs and Vaccines Sales by Type (K Units) Table 24. Global Pediatric Drugs and Vaccines Market Size by Type (M USD) Table 25. Global Pediatric Drugs and Vaccines Sales (K Units) by Type (2017-2022) Table 26. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2022) Table 27. Global Pediatric Drugs and Vaccines Market Size (M USD) by Type (2017-2022) Table 28. Global Pediatric Drugs and Vaccines Market Size Share by Type (2017-2022) Table 29. Global Pediatric Drugs and Vaccines Price (USD/Unit) by Type (2017-2022) Table 30. Global Pediatric Drugs and Vaccines Sales (K Units) by Application Table 31. Global Pediatric Drugs and Vaccines Market Size by Application Table 32. Global Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (K Units) Table 33. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2022) Table 34. Global Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (M USD) Table 35. Global Pediatric Drugs and Vaccines Market Share by Application (2017-2022) Table 36. Global Pediatric Drugs and Vaccines Sales Growth Rate by Application (2017-2022) Table 37. Global Pediatric Drugs and Vaccines Sales by Region (2017-2022) & (K Units) Table 38. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2017-2022) Table 39. North America Pediatric Drugs and Vaccines Sales by Country (2017-2022) & (K Units) Table 40. Europe Pediatric Drugs and Vaccines Sales by Country (2017-2022) & (K Units) Table 41. Asia Pacific Pediatric Drugs and Vaccines Sales by Region (2017-2022) & (K Units) Table 42. South America Pediatric Drugs and Vaccines Sales by Country (2017-2022) & (K Units) Table 43. Middle East and Africa Pediatric Drugs and Vaccines Sales by Region (2017-2022) & (K Units) Table 44. Merck and Co., Inc. (USA) Pediatric Drugs and Vaccines Basic Information Table 45. Merck and Co., Inc. (USA) Pediatric Drugs and Vaccines Product Overview Table 46. Merck and Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 47. Merck and Co., Inc. (USA) Business Overview Table 48. Merck and Co., Inc. (USA) Pediatric Drugs and Vaccines SWOT Analysis Table 49. Merck and Co., Inc. (USA) Recent Developments Table 50. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Basic Information Table 51. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Overview Table 52. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 53. Abbott Laboratories (USA) Business Overview Table 54. Abbott Laboratories (USA) Pediatric Drugs and Vaccines SWOT Analysis Table 55. Abbott Laboratories (USA) Recent Developments Table 56. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Basic Information Table 57. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Overview Table 58. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 59. Amgen, Inc. (USA) Business Overview Table 60. Amgen, Inc. (USA) Pediatric Drugs and Vaccines SWOT Analysis Table 61. Amgen, Inc. (USA) Recent Developments Table 62. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Basic Information Table 63. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Overview Table 64. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Eli Lilly and Company (USA) Business Overview Table 66. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines SWOT Analysis Table 67. Eli Lilly and Company (USA) Recent Developments Table 68. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Basic Information Table 69. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Overview Table 70. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 71. F. Hoffmann-La Roche Ltd (Switzerland) Business Overview Table 72. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines SWOT Analysis Table 73. F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments Table 74. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Basic Information Table 75. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Overview Table 76. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Genentech, Inc. (USA) Business Overview Table 78. Genentech, Inc. (USA) Recent Developments Table 79. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Basic Information Table 80. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Overview Table 81. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. GlaxoSmithKline plc. (UK) Business Overview Table 83. GlaxoSmithKline plc. (UK) Recent Developments Table 84. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Basic Information Table 85. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Overview Table 86. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. Janssen Biologics B.V. (USA) Business Overview Table 88. Janssen Biologics B.V. (USA) Recent Developments Table 89. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Basic Information Table 90. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Overview Table 91. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. Actelion Pharmaceuticals Business Overview Table 93. Actelion Pharmaceuticals Recent Developments Table 94. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Basic Information Table 95. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Overview Table 96. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. AstraZeneca Plc. (UK) Business Overview Table 98. AstraZeneca Plc. (UK) Recent Developments Table 99. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Basic Information Table 100. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Overview Table 101. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 102. Boehringer Ingelheim GmbH (Germany) Business Overview Table 103. Boehringer Ingelheim GmbH (Germany) Recent Developments Table 104. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Basic Information Table 105. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Overview Table 106. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 107. Bristol-Myers Squibb Company (USA) Business Overview Table 108. Bristol-Myers Squibb Company (USA) Recent Developments Table 109. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Basic Information Table 110. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Overview Table 111. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 112. Allergan, Inc. (USA) Business Overview Table 113. Allergan, Inc. (USA) Recent Developments Table 114. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Basic Information Table 115. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Overview Table 116. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 117. Novartis AG (Switzerland) Business Overview Table 118. Novartis AG (Switzerland) Recent Developments Table 119. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Basic Information Table 120. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Overview Table 121. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 122. Novo Nordisk A/S (Denmark) Business Overview Table 123. Novo Nordisk A/S (Denmark) Recent Developments Table 124. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Basic Information Table 125. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Overview Table 126. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 127. Pfizer, Inc. (USA) Business Overview Table 128. Pfizer, Inc. (USA) Recent Developments Table 129. Sanofi S.A (France) Pediatric Drugs and Vaccines Basic Information Table 130. Sanofi S.A (France) Pediatric Drugs and Vaccines Product Overview Table 131. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 132. Sanofi S.A (France) Business Overview Table 133. Sanofi S.A (France) Recent Developments Table 134. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Basic Information Table 135. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Overview Table 136. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 137. Shionogi Inc. (USA) Business Overview Table 138. Shionogi Inc. (USA) Recent Developments Table 139. Takeda Pediatric Drugs and Vaccines Basic Information Table 140. Takeda Pediatric Drugs and Vaccines Product Overview Table 141. Takeda Pediatric Drugs and Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 142. Takeda Business Overview Table 143. Takeda Recent Developments Table 144. Global Pediatric Drugs and Vaccines Sales Forecast by Region (K Units) Table 145. Global Pediatric Drugs and Vaccines Market Size Forecast by Region (M USD) Table 146. North America Pediatric Drugs and Vaccines Sales Forecast by Country (2022-2028) & (K Units) Table 147. North America Pediatric Drugs and Vaccines Market Size Forecast by Country (2022-2028) & (M USD) Table 148. Europe Pediatric Drugs and Vaccines Sales Forecast by Country (2022-2028) & (K Units) Table 149. Europe Pediatric Drugs and Vaccines Market Size Forecast by Country (2022-2028) & (M USD) Table 150. Asia Pacific Pediatric Drugs and Vaccines Sales Forecast by Region (2022-2028) & (K Units) Table 151. Asia Pacific Pediatric Drugs and Vaccines Market Size Forecast by Region (2022-2028) & (M USD) Table 152. South America Pediatric Drugs and Vaccines Sales Forecast by Country (2022-2028) & (K Units) Table 153. South America Pediatric Drugs and Vaccines Market Size Forecast by Country (2022-2028) & (M USD) Table 154. Middle East and Africa Pediatric Drugs and Vaccines Consumption Forecast by Country (2022-2028) & (Units) Table 155. Middle East and Africa Pediatric Drugs and Vaccines Market Size Forecast by Country (2022-2028) & (M USD) Table 156. Global Pediatric Drugs and Vaccines Sales Forecast by Type (2022-2028) & (K Units) Table 157. Global Pediatric Drugs and Vaccines Market Size Forecast by Type (2022-2028) & (M USD) Table 158. Global Pediatric Drugs and Vaccines Price Forecast by Type (2022-2028) & (USD/Unit) Table 159. Global Pediatric Drugs and Vaccines Sales (K Units) Forecast by Application (2022-2028) Table 160. Global Pediatric Drugs and Vaccines Market Size Forecast by Application (2022-2028) & (M USD) LIST OF FIGURES Figure 1. Product Picture of Pediatric Drugs and Vaccines Figure 2. Data Triangulation Figure 3. Key Caveats Figure 4. Global Pediatric Drugs and Vaccines Market Size (M USD), 2017-2028 Figure 5. Global Pediatric Drugs and Vaccines Market Size (M USD) (2017-2028) Figure 6. Global Pediatric Drugs and Vaccines Sales (K Units) & (2017-2028) Figure 7. Evaluation Matrix of Segment Market Development Potential (Type) Figure 8. Evaluation Matrix of Segment Market Development Potential (Application) Figure 9. Evaluation Matrix of Regional Market Development Potential Figure 10. Pediatric Drugs and Vaccines Market Size (M USD) by Country (M USD) Figure 11. Pediatric Drugs and Vaccines Sales Share by Manufacturers in 2020 Figure 12. Global Pediatric Drugs and Vaccines Revenue Share by Manufacturers in 2020 Figure 13. Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 14. Global Market Pediatric Drugs and Vaccines Average Price (USD/Unit) of Key Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Players: Market Share by Pediatric Drugs and Vaccines Revenue in 2021 Figure 16. Evaluation Matrix of Segment Market Development Potential (Type) Figure 17. Global Pediatric Drugs and Vaccines Market Share by Type Figure 18. Sales Market Share of Pediatric Drugs and Vaccines by Type (2017-2022) Figure 19. Sales Market Share of Pediatric Drugs and Vaccines by Type in 2021 Figure 20. Market Size Share of Pediatric Drugs and Vaccines by Type (2017-2022) Figure 21. Market Size Market Share of Pediatric Drugs and Vaccines by Type in 2020 Figure 22. Evaluation Matrix of Segment Market Development Potential (Application) Figure 23. Global Pediatric Drugs and Vaccines Market Share by Application Figure 24. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2022) Figure 25. Global Pediatric Drugs and Vaccines Sales Market Share by Application in 2021 Figure 26. Global Pediatric Drugs and Vaccines Market Share by Application (2017-2022) Figure 27. Global Pediatric Drugs and Vaccines Market Share by Application in 2020 Figure 28. Global Pediatric Drugs and Vaccines Sales Growth Rate by Application (2017-2022) Figure 29. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2017-2022) Figure 30. North America Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 31. North America Pediatric Drugs and Vaccines Sales Market Share by Country in 2020 Figure 32. U.S. Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 33. Canada Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2017-2022) Figure 34. Mexico Pediatric Drugs and Vaccines Sales (Units) and Growth Rate (2017-2022) Figure 35. Europe Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 36. Europe Pediatric Drugs and Vaccines Sales Market Share by Country in 2020 Figure 37. Germany Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 38. France Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 39. U.K. Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 40. Italy Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 41. Russia Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 42. Asia Pacific Pediatric Drugs and Vaccines Sales and Growth Rate (K Units) Figure 43. Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Region in 2020 Figure 44. China Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 45. Japan Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 46. South Korea Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 47. India Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 48. Southeast Asia Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 49. South America Pediatric Drugs and Vaccines Sales and Growth Rate (K Units) Figure 50. South America Pediatric Drugs and Vaccines Sales Market Share by Country in 2020 Figure 51. Brazil Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 52. Argentina Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 53. Columbia Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 54. Middle East and Africa Pediatric Drugs and Vaccines Sales and Growth Rate (K Units) Figure 55. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Region in 2020 Figure 56. Saudi Arabia Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 57. UAE Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 58. Egypt Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 59. Nigeria Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 60. South Africa Pediatric Drugs and Vaccines Sales and Growth Rate (2017-2022) & (K Units) Figure 61. Global Pediatric Drugs and Vaccines Sales Forecast by Volume (2017-2028) & (K Units) Figure 62. Global Pediatric Drugs and Vaccines Market Size Forecast by Value (2017-2028) & (M USD) Figure 63. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Type (2022-2028) Figure 64. Global Pediatric Drugs and Vaccines Market Share Forecast by Type (2022-2028) Figure 65. Global Pediatric Drugs and Vaccines Sales Forecast by Application (2022-2028) Figure 66. Global Pediatric Drugs and Vaccines Market Share Forecast by Application (2022-2028)

•Merck and Co., Inc. (USA) •Abbott Laboratories (USA) •Amgen, Inc. (USA) •Eli Lilly and Company (USA) •F. Hoffmann-La Roche Ltd (Switzerland) •Genentech, Inc. (USA) •GlaxoSmithKline plc. (UK) •Janssen Biologics B.V. (USA) •Actelion Pharmaceuticals •AstraZeneca Plc. (UK) •Boehringer Ingelheim GmbH (Germany) •Bristol-Myers Squibb Company (USA) •Allergan, Inc. (USA) •Novartis AG (Switzerland) •Novo Nordisk A/S (Denmark) •Pfizer, Inc. (USA) •Sanofi S.A (France) •Shionogi Inc. (USA) •Takeda